Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Catherine L. Akay Image

      Catherine L. Akay, M.D.

      Department of Breast Surgical Oncology, Division of Surgery

      About Dr. Catherine L. Akay

      Dr. Catherine Akay is an Associate Professor in the Department of Breast Surgical Oncology at the University of Texas MD Anderson Cancer Center. She is board certified by the American Board of Surgery and a fellow of the Society of Surgical Oncology. She is an investigator on multiple clinical trials in breast cancer. Her research interests include perineural invasion in breast cancer and de-escalation of axillary surgery to minimize lymphedema risk.


      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Associate Professor, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2003Saint Louis University School of Medicine, Saint Louis, Missouri, US, MD
      1999University of Pennsylvania, Philadelphia, Pennsylvania, US, Neuroscience, BA

      Postgraduate Training

      2010-2011Clinical Fellowship, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2005-2007Research Fellowship, Perineural invasion and mechanisms of tumor cell metastasis, Baylor College of Medicine, Houston, Texas
      2004-2010Clinical Residency, General Surgery, Baylor College of Medicine, Houston, Texas
      2003-2004Clinical Internship, General Surgery, Baylor College of Medicine, Houston, Texas

      Licenses & Certifications

      2011American Board of Surgery
      2006Texas Medical Board

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2019

      Clinical Specialist, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2011

      Other Professional Positions

      Faculty Consultant, Breast Surgical Oncology, MD Anderson Cancer Network, Houston, Texas, 2019 - 2025

      Intramural Institutional Committee Activities

      Breast surgical oncology representative, MD Anderson Northwest Hospital Medical Appropriateness Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2023

      Breast Surgical Oncology Representative, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Breast Surgery Representative for Houston Area Locations, Operating Room and Inpatient Clinical Coverage Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Breast Surgery Lead, HAL Clinical Research Expansion Operations Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2022

      Extramural Institutional Committee Activities

      Breast Surgical Oncology Lead, MD Anderson Cancer Network, Multidisciplinary Site Integration - Baptist, Jacksonville, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Honors & Awards

      2011Corynne S. Uhl Award for Compassion and Excellent Care, The University of Texas MD Anderson Cancer Center
      2009Administrative Chief Resident, Michael E DeBakey Department of Surgery
      2009Raleigh Ross Scholar, Texas Surgical Society
      2006 - 2007Resident Research Award, Association for Academic Surgery
      2005 - 2006Young Investigator Award, Baylor College of Medicine
      1995National Merit Scholarship Finalist

      Professional Memberships

      American Society of Breast Surgeons

      2013 - Present

      American Society of Clinical Oncologists

      2010 - Present

      American College of Surgeons

      2010 - Present

      Society of Surgical Oncology

      2010 - Present

      Michael E. DeBakey International Surgical Society

      2004 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2016. Clinical Evaluation of Breast Lesions. Invited. Houston Society of Clinical Pathologists Annual Meeting. Houston, Texas, US.
      2. 2016. Surgical Management of In Situ Lesions of the Breast. Invited. Houston Society of Clinical Pathologists Annual Meeting. Houston, Texas, US.

      National Presentations

      1. 2021. An Exploratory Case-Control Study of Perineural Invasion in Breast Cancer. Poster. San Antonio Breast Cancer Symposium. San Antonio, Texas, US.
      2. 2015. Surgical Considerations in Patients Receiving Neoadjuvant Chemotherapy. Invited. The American Society of Breast Surgeons Annual Meeting. Orlando, Florida, US.
      3. 2012. Primary Tumor Resection as a Component of Multimodality Treatment May Improve Survival and Local Disease Control in Stage IV Inflammatory Breast Cancer. Poster. American Society of Clinical Oncology Annual Meeting. Chicago, Illinois, US.
      4. 2012. Intraoperative Evaluation of Sentinel Lymph Nodes is Accurate After Neoadjuvant Therapy for Breast Cancer. Poster. Society of Surgical Oncology Annual Cancer Symposium. Orlando, Florida, US.
      5. 2011. Validation of a Prognostic Index Score for Local-Regional Recurrence after Mastectomy or Breast Conservation Therapy in Patients Treated with Neoadjuvant Chemotherapy. Conference. Society of Surgical Oncology Annual Cancer Symposium. San Antonio, Texas, US.
      6. 2008. Angiocidin Expression is an Independent Prognostic Factor of Outcome in Colorectal Cancer. Conference. Annual Academic Surgical Congress. Huntington Beach, California, US.
      7. 2008. Silencing Angiocidin Expression Reduces Tumorigenicity of Colon Cancer Cells. Conference. Annual Academic Surgical Congress. Huntington Beach, California, US.
      8. 2007. Perineural Invasion is a Significant Prognostic Indicator in Colorectal Cancer. Poster. Society of Surgical Oncology Annual Cancer Symposium. Washington, DC, US.
      9. 2007. Angiocidin Inhibition by Two Novel Peptides Decreases Tumor Burden in a Nude Mouse Colon Cancer Model. Conference. Annual Academic Surgical Congress. Phoenix, Arizona, US.
      10. 2007. Perineural Invasion is a Significant Prognostic Indicator in Colorectal Cancer. Poster. American Society of Clinical Oncology Gastrointestinal Cancers Symposium,. Orlando, Florida, US.

      International Presentations

      1. 2017. Multidisciplinary Case Discussion. Invited. Turkish National Breast Diseases Congress. Antalya, TR.
      Read More
      Less

      Grant & Contract Support

      Date: 2021 - 2023
      Title:5354-CL-1201: A Phase 2 Open-label, Dose-finding Study to Determine the Optimal dose for Lymph Node Visualization using ASP5354 in Participants with Breast Cancer or Melanoma Undergoing Sentinel Lymph Node Biopsy
      Funding Source:Astellas Pharma US
      Role:PI
      ID:00060236

      Selected Publications

      Peer-Reviewed Articles

      1. Schaverien, MV, Singh, P, Kuerer, HM, Akay, CL, Chavez Mac Gregor, M, Chu, K, Clemens, MW, Qiao, W, Smith, B, Hoffman, K. Comparison of Outcomes of Microsurgical Breast Reconstruction after Premastectomy and Postmastectomy Radiation Therapy. Journal of the American College of Surgeons 241(4):535-549, 2025. e-Pub 2025. PMID: 40366003.
      2. Schaverien MV, Singh P, Smith BD, Qiao W, Akay CL, Bloom ES, Chavez-MacGregor M, Chu CK, Clemens MW, Colen JS, Ehlers RA, Hwang RF, Joyner MM, Largo RD, Mericli AF, Mitchell MP, Shuck JW, Tamirisa N, Tripathy D, Villa MT, Woodward WA, Zacharia R, Kuerer HM, Hoffman KE. Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial. JAMA Netw Open 7(4):e245217, 2024. e-Pub 2024. PMID: 38578640.
      3. Boukovalas S, Liu J, Asaad M, Schaverien MV, Akay C, Garvey PB, Hwang RF, Offodile AC. Relationship Between Financial Toxicity and Surgical Treatment for Early-Stage Breast Cancer: A Propensity Score-Matched Comparison of Breast-Conserving Therapy and Mastectomy. J Am Coll Surg. 2021 Sep;233(3):445-456 233(3):445-456.e2, 2021. e-Pub 2021. PMID: 34111529.
      4. Santiago L, Volk RJ, Checka CM, Black D, Lee J, Colen JS, Akay C, Caudle A, Kuerer H, Arribas EM. Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study. J Surg Oncol, 2021. e-Pub 2021. PMID: 33577715.
      5. DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, Woodward WA, Kuerer HM, Akay CL, Babiera GV, Yang W, Lucci A. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer. Clin Breast Cancer, 2018. e-Pub 2018. PMID: 28755879.
      6. Akay CL, Albarracin C, Torstenson T, Bassett R, Mittendorf EA, Yi M, Kuerer HM, Babiera GV, Bedrosian I, Hunt KK, Hwang RF. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer. Breast J, 2018. e-Pub 2018. PMID: 28608612.
      7. Xiang DB, Wei B, Abraham SC, Huo L, Albarracin CT, Zhang H, Babiera G, Caudle AS, Akay CL, Rao P, Zhao YJ, Lu X, Wu Y. Molecular cytogenetic characterization of mammary neuroendocrine carcinoma. Hum Pathol 45(9):1951-6, 2014. e-Pub 2014. PMID: 25074542.
      8. Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt KK, Huo L, Babiera GV. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer 120(9):1319-28, 2014. e-Pub 2014. PMID: 24510381.
      9. Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez R, Hoffman K, Perkins G, Strom E, Buchholz T, Ueno N, Babiera G, Woodward W. Predictors of Durable No Evidence of Disease Status in de novo Metastatic Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Post-Mastectomy Radiation. Springerplus, 2014. e-Pub 2014. PMID: 24711988.
      10. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol 19(3):901-7, 2012. e-Pub 2012. PMID: 21861223.
      11. Albo D, Akay CL, Marshall CL, Wilks JA, Verstovsek G, Liu H, Agarwal N, Berger DH, Ayala GE. Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes. Cancer 117(21):4834-45, 2011. e-Pub 2011. PMID: 21480205.
      12. Liebig C, Wilks JA, Feig BW, Wang TN, Wilson M, Herdman AV, Albo D. The role of angiocidin in sarcomas. Cancer 115(22):5251-62, 2009. e-Pub 2009. PMID: 19634159.
      13. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, Berger DH, Albo D. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 27(31):5131-7, 2009. e-Pub 2009. PMID: 19738119.
      14. Wilks JA, Liebig C, Tasleem SH, Haderxhanaj K, Lee L, Farrow B, Awad S, Berger D, Albo D. Rectal cancer patients benefit from implementation of a dedicated colorectal cancer center in a Veterans Affairs Medical Center. Am J Surg 198(1):100-4, 2009. e-Pub 2009. PMID: 19268899.
      15. Liebig C, Agarwal N, Ayala GE, Verstovsek G, Tuszynski GP, Albo D. Angiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model. J Surg Res 142(2):320-6, 2007. e-Pub 2007. PMID: 17719063.
      16. Huang, ML, Chang Sen LQ, Lane DL, Candelaria RP, Kuerer HM, Hunt KK, Akay CL, Lim B, Shaitelman, SF, Hwang R, Chen H, Katta R, Santiago L. Defining breast cryoablation treatment success: a guide for the curative and palliative treatment of breast cancer. Academic Radiology. PMID: 39107186.
      17. Schaverien, M.V., Singh, P., Kuerer, H.M., Akay, C.L., Chavez-MacGregor, M., Chu, C.K., Clemens, M. W., Qiao, W., Smith, B.D., Hoffman, K.E.. Comparison of Outcomes of Microsurgical Breast Reconstruction After Premastectomy and Postmastectomy Radiation Therapy 240(5):700-710.

      Invited Articles

      1. Akay CL. Invited Commentary on Margin Width Should Not Still Enforce a Systematic Surgical Re-excision in the Conservative Treatment of Early Breast Infiltrative Ductal Carcinoma in Breast Diseases: A Year Book Quarterly. Breast Diseases 25(3):245-6, 2014. e-Pub 2014.

      Review Articles

      1. Akay CL. Perineural Invasion in Cancer: a Review of the Literature. Cancer, 2009. e-Pub 2009. PMID: 19484787.

      Professional Educational Materials

      1. Akay C. Breast Education Self-Assessment Program II. The American Society of Breast Surgeons, 2015.
      2. Akay C. Breast Education Self-Assessment Program. The American Society of Breast Surgeons, 2014.

      Abstracts

      1. Marshall CL, Orcutt ST, Ayala GE, Balentive CJ, Robinson CN, Akay CL, Dh B, Albo D. Stage II Colorectal Cancer Patients with Perineural Invasion Benefit from Adjuvant Chemotheraphy. Annals of Surgical Oncology 18(s76), 2011. e-Pub 2011.
      2. Wilks JA, Liebig C, Tasleem SH, Haderxhanaj K, etal. A Dedicated Colorectal Cancer Center in a Medical Center Provides Higher Quality of Care of Colorectal Cancer Patients. Journal of Surgical Research 151(2):238, 2009. e-Pub 2009.
      3. Wilks JA, Agarwal N, Liebig C, Shen X, etal. Angiocidin siRNA Inhibits Colon Cancer Growth in Vivo. Journal of Surgical Research 151(2):196-7, 2009. e-Pub 2009.
      4. Wilks JA, Liebig C, Agarawal N, etal. Thrombospondin-1, through Angiocidin, Up-regulates Gelatinase Expression in Colon Cancer Cells. Journal of Surgical Research 151(2):197-8, 2009. e-Pub 2009.
      5. Wilks JA, Liebig C, Haderxhanaj K, Saad M, Berger D, etal. Improvements in Colon Cancer Health Care Delivery with Implementation of a Dedicated Colorectal Cancer Center. Journal of the American College of Surgeons 207(3s):80-1, 2008. e-Pub 2008.
      6. Liebig CA, Wilks JA, Agarwal N, Verstovsek G, etal. Angiocidin: An Independent Prognostic Factor of Outcome in Colon Cancer. Journal of Surgical Research 144(2):220-221, 2008. e-Pub 2008.
      7. Agarwal N, Liebig C, Wilks J, Albo D. Silencing Angiocidin Expression Reduces Tumorigenicity of Colon Cancer Cells. Journal of Surgical Research 144(2):237-8, 2008. e-Pub 2008.
      8. Agarawal N, Liebig C, Wilks JA, Tusznski JP, etal. Structural Anaylsis and Cellular Distribution of Angiocidin in Cancer Cells. Journal of Surgical Research 144(2):306-7, 2008. e-Pub 2008.
      9. Liebig CA, Wilks JA, Agarwal N, Verstovsek G, etal. Neurogenesis in Colorectal Cancer. Journal of Surgical Research 144(2):220-1, 2008. e-Pub 2008.
      10. Liebig C, Agarwal N, Ayala G, Verstovsek G. Inhibition of Angiocidin by Two Novel Peptides Decreases Tumor Burden in an Orthotopic Nude Mouse Model. Journal of Surgical Research 137(2):183, 2007. e-Pub 2007.
      11. Agarwal N, Liebig C, Tuszynski GP, Bharadway U, Albo D. Fibroblasts Up-regulate Gelatinase Activity and Promote Tumor Cell Invasion in Colon Cancer Through Angiocidin. Journal of Surgical Research 137(2):222, 2007. e-Pub 2007.
      12. Leonard LD, Sun J, Bassett, R, Ehlers R, Refinetti A, Johnson H, Akay CL, Suarez Colon J, Bedrosian I, Hunt K,, Tamirisa N.. Surgeon Interpretation of Margin Status Utilizing Intraoperative 3D Tomosynthesis During Breast Conserving Surgery. American Society of Breast Surgeon's 26th Annual Meeting.

      Book Chapters

      1. Akay CL, Meric-Bernstam F. Treatment of Advanced Breast Cancer. In: Surgery. JP Publishing, 2013.
      2. Akay CL, Kuerer HM, Hwang RF. Sential Lymph Node Biopsy in Breast Cancer: MD Anderson Cancer Center Approach. In: Advanced Therapy of Breast Diseases. Singletary, Robb and Hortobagyi, 2011.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top